, Tracking Stock Market Picks
Enter Symbol:
Amarin Corporation Plc (AMRN) [hlAlert]

Neutral AMRN
down 69.62 %

Amarin Corporation Plc (AMRN) downgraded to Neutral by Sun Trust Rbsn Humphrey

Posted on: Thursday,  Oct 17, 2013  8:25 AM ET by Sun Trust Rbsn Humphrey

Sun Trust Rbsn Humphrey rated Neutral Amarin Corporation Plc (NASDAQ: AMRN) on 10/17/2013. Previously Sun Trust Rbsn Humphrey rated Buy Amarin Corporation Plc (NASDAQ:
AMRN) on 09/04/2013., when the stock price was $6.42. Since then, Amarin Corporation Plc has lost 69.63% as of 10/17/2013's recent price of $1.95.
If you would have followed the previous Sun Trust Rbsn Humphrey's recommendation on AMRN, you would have lost 69.62% of your investment in 43 days.

Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical company with a focus on cardiovascular disease. Amarin has a range of clinical and preclinical stage compounds to treat central nervous system (CNS) disorders, including Huntington?s disease, myasthenia gravis and Parkinson?s disease. Its cardiovascular programs and non-core CNS programs include AMR101, EN101, Sublingual Apomorphine and AMR 103. The Company's subsidiaries include Amarin Neuroscience Limited, Amarin Pharmaceuticals Ireland Limited, Amarin Pharma Inc, Amarin Finance Limited and Ester Neurosciences Limited.

We provide equity research coverage on more than 300 companies in select core industries and sub-sectors with above-average growth potential. Our focused approach allows our analysts to have deep knowledge of industries, companies and markets they cover, enabling them to deliver highly insightful research and sound advice. With our expertise and thoughtful, diligent approach, our equity research positions you to make well-informed decisions that contribute to your success.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/17/2013 8:25 AM Hold
as of 12/13/2013
1 Week   
1 Month   
3 Months down  -70.45 %
1 YTD down  -69.62 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/4/2013 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy